DekaBank Deutsche Girozentrale’s Merrimack Pharmaceuticals, Inc. MACK Stock Holding History

DekaBank Deutsche Girozentrale’s Portfolio MACK Stock Details MACK Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2018 Q1	–	Sell	-34,953	Closed	-$35K	–	1244
2017 Q4	$35K	Hold	34,953	–	–	﹤0.01%	1024
2017 Q3	$35K	Buy	34,953 +31,458	+900%	+$331K	﹤0.01%	1032
2017 Q2	$35K	Hold	3,495	–	–	﹤0.01%	1021
2017 Q1	$84K	Sell	3,495 -318	-8%	-$7.96K	﹤0.01%	917
2016 Q4	$126K	Buy	+3,813	New	+$163K	﹤0.01%	902
2016 Q3	–	Sell	-8,897	Closed	-$393K	–	1063
2016 Q2	$393K	Buy	8,897 +2,542	+40%	+$138K	﹤0.01%	720
2016 Q1	$407K	Sell	6,355 -826	-12%	-$43.1K	﹤0.01%	694
2015 Q4	$457K	Buy	7,181 +127	+2%	+$8.94K	0.01%	714
2015 Q3	$472K	Buy	7,054 +445	+7%	+$36.3K	0.01%	705
2015 Q2	$643K	Buy	6,609 +241	+4%	+$22.9K	0.01%	651
2015 Q1	$595K	Sell	6,368 -750	-11%	-$63.8K	0.01%	679
2014 Q4	$621K	Sell	7,118 -635	-8%	-$46.3K	0.01%	645
2014 Q3	$536K	Buy	7,753 +191	+3%	+$10.2K	0.01%	639
2014 Q2	$434K	Sell	7,562 -509	-6%	-$25.8K	0.01%	630
2014 Q1	$320K	Buy	8,071 +699	+9%	+$29.9K	0.01%	653
2013 Q4	$299K	Buy	7,372 +572	+8%	+$16.6K	﹤0.01%	613
2013 Q3	$212K	Buy	6,800 +381	+6%	+$13.3K	﹤0.01%	656
2013 Q2	$330K	Buy	+6,419	New	+$281K	0.01%	486

Other funds holding MACK

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

TCIM

TIAA CREF Investment Management New York $141B AUM 14.18% 1-Year Est. Return

RCMNY

Rubric Capital Management (New York) New York $9.44B AUM 68.42% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return

Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return

Deutsche Bank Frankfurt Am Main Ge, Germany $303B AUM 30.15% 1-Year Est. Return

Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

DekaBank Deutsche Girozentrale's MACK Position: Q1 2018 in Review

DekaBank Deutsche Girozentrale sold out of Merrimack Pharmaceuticals, Inc. (MACK) in Q1 2018, closing a stake of 34,953 shares — an estimated $35K sold.

DekaBank Deutsche Girozentrale first reported a position in MACK in Q2 2013 and held it in 18 quarters. The position peaked at $643K in Q2 2015. 81 funds tracked by Wall St. Rank hold MACK as of Q1 2018.

DekaBank Deutsche Girozentrale reported no remaining Merrimack Pharmaceuticals, Inc. position as of Q1 2018 after selling out during the quarter.
DekaBank Deutsche Girozentrale sold 34,953 Merrimack Pharmaceuticals, Inc. shares in Q1 2018, an estimated $35K.
DekaBank Deutsche Girozentrale first reported a position in Merrimack Pharmaceuticals, Inc. in Q2 2013 and held it in 18 quarters.
DekaBank Deutsche Girozentrale's Merrimack Pharmaceuticals, Inc. position peaked at $643K in Q2 2015.
81 funds tracked by Wall St. Rank held Merrimack Pharmaceuticals, Inc. as of Q1 2018.

Based on DekaBank Deutsche Girozentrale's 13F filing for Q1 2018, filed 3 May 2018.